Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price & Analysis
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) rose 0.57% to USD 3.5 as of September 8, 2026 at 09:33 UTC, according to Nexqual real-time market data.
SHPH last closed at USD 3.5; the session ranged USD 3.4–3.59 on volume of 9,081 shares. Market capitalization is —, with a 52-week range of USD 2.58–55.9 (NCM). Source: Nexqual, September 8, 2026 at 09:33 UTC.
Key Statistics (as of September 8, 2026 at 09:33 UTC)
| Price | USD 3.5 |
|---|---|
| Change | ▲ 0.57% (up) |
| Previous Close | USD 3.5 |
| Open | USD 3.5 |
| Day Range | USD 3.4 – 3.59 |
| 52-Week Range | USD 2.58 – 55.9 |
| Volume | 9,081 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (SHPH)
Nexqual's technical model rates SHPH "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:33 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.73 (neutral) |
| vs SMA50 | Below (USD 3.57) |
| MACD | -0.08 (negative) |
From Shuttle Pharmaceuticals Holdings, Inc.'s Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- The platform will increasingly support insights that connect chemical properties with biological implications, which creates a more complete, end-to-end picture for early research teams.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIAF | bioAffinity Technologies, Inc. | USD 15.27 | ▲ 56.62% |
| ATXG | Addentax Group Corp. | USD 3.65 | ▲ 9.48% |
| VRAX | Virax Biolabs Group Limited | USD 2.63 | ▲ 3.14% |
| QNRX | Quoin Pharmaceuticals, Ltd. | USD 7.26 | ▲ 7.72% |
| PXMD | PaxMedica, Inc. | USD 0 | ▼ 28.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:33 UTC. This page is informational and not investment advice.